Publication Name	World Journal of Hepatology
Manuscript ID	26947
Country	Italy

Received	2016-05-02 17:32
Peer-Review Started	2016-05-03 12:13
To Make the First Decision	2016-06-12 09:38
Return for Revision	2016-06-17 16:41
Revised	2016-07-01 01:14
Second Decision	2016-07-05 17:42
Accepted by Journal Editor-in-Chief	2016-07-05 17:49
Accepted by Executive Editor-in-Chief	2016-07-18 10:52
Articles in Press	2016-07-18 10:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-08-09 16:28
Publish the Manuscript Online	2016-08-25 10:46

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension
Manuscript Source	Invited Manuscript
All Author List	Alberto Ferrarese, Alberto Zanetto, Giacomo Germani, Patrizia Burra and Marco Senzolo
Funding Agency and Grant Number
Corresponding Author	Dr. Marco Senzolo, MD, PhD, Multivi­sceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, via Giustiniani 2, 35128 Padua, Italy. marcosenzolo@hotmail.com
Key Words	Beta blockers; Ascites; Cirrhosis; Portal hypertension
Core Tip	In this review, we’ve critically analyzed the recent evidence on the role played by non-selective beta blockers in patients with decompensated liver disease.
Publish Date	2016-08-25 10:46
Citation	Ferrarese A, Zanetto A, Germani G, Burra P, Senzolo M. Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension. World J Hepatol 2016; 8(24): 1012-1018
URL	http://www.wjgnet.com/1948-5182/full/v8/i24/1012.htm
DOI	http://dx.doi.org/10.4254/wjh.v8.i24.1012

Full Article (PDF)	WJH-8-1012.pdf
Full Article (Word)	WJH-8-1012.doc
Manuscript File	26947-Review.docx
Answering Reviewers	26947-Answering reviewers.pdf
Audio Core Tip	26947-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	26947-Conflict-of-interest statement.pdf
Copyright License Agreement	26947-Copyright assignment.pdf
Peer-review Report	26947-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	26947-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	26947-Scientific misconduct check.pdf
Scientific Editor Work List	26947-Scientific editor work list.pdf